LeMaitre Vascular, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5255582018
USD
81.45
0.63 (0.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
70.38
66.55
64.45
61.05
64.23
59.87
55.72
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
70.38
66.55
64.45
61.05
64.23
59.87
55.72
Raw Material Cost
21.03
19.57
18.26
16.53
20.70
19.87
17.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.30
1.30
1.30
1.30
1.30
1.29
0.20
Selling and Distribution Expenses
24.10
25.15
23.82
21.23
23.85
23.28
22.05
Other Expenses
0.35
0.28
0.22
0.17
0.22
0.28
0.34
Total Expenditure (Excl Depreciation)
49.98
48.78
45.62
40.73
48.09
47.24
42.80
Operating Profit (PBDIT) excl Other Income
20.4
17.8
18.799999999999997
20.299999999999997
16.1
12.6
12.9
Other Income
3.09
3.20
2.77
3.56
3.23
2.90
1.37
Operating Profit (PBDIT)
26.15
23.59
24.20
26.48
22.02
18.08
16.71
Interest
1.30
1.30
1.30
1.30
1.30
1.29
0.20
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
-0.06
Gross Profit (PBDT)
49.35
46.98
46.19
44.51
43.54
40.00
38.59
Depreciation
2.66
2.62
2.60
2.61
2.65
2.55
2.42
Profit Before Tax
22.19
19.67
20.30
22.57
18.07
14.24
14.02
Tax
5.14
3.99
4.72
5.21
4.29
3.23
2.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.05
15.68
15.58
17.36
13.78
11.01
11.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.05
15.68
15.58
17.36
13.78
11.01
11.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
17.05
15.68
15.58
17.36
13.78
11.01
11.18
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
420.34
406.62
393.52
378.92
362.69
347.57
337.29
Earnings per share (EPS)
0.69
0.68
0.68
0.75
0.6
0.48
0.49
Diluted Earnings per share
0.69
0.68
0.68
0.75
0.6
0.48
0.49
Operating Profit Margin (Excl OI)
28.98%
26.71%
29.22%
33.27%
25.13%
21.09%
23.19%
Gross Profit Margin
35.31%
33.5%
35.54%
41.26%
32.25%
28.05%
29.5%
PAT Margin
24.22%
23.56%
24.18%
28.44%
21.45%
18.39%
20.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 9.66% vs 15.05% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 23.91% vs 16.95% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 22.87% vs 11.90% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of LeMaitre Vascular, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
70.38
200.40
-130.02
-64.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
70.38
200.40
-130.02
-64.88%
Raw Material Cost
21.03
70.70
-49.67
-70.25%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.30
4.10
-2.80
-68.29%
Selling and Distribution Expenses
24.10
127.90
-103.80
-81.16%
Other Expenses
0.35
2.30
-1.95
-84.78%
Total Expenditure (Excl Depreciation)
49.98
225.70
-175.72
-77.86%
Operating Profit (PBDIT) excl Other Income
20.40
-25.30
45.70
180.63%
Other Income
3.09
0.70
2.39
341.43%
Operating Profit (PBDIT)
26.15
-12.00
38.15
317.92%
Interest
1.30
4.10
-2.80
-68.29%
Exceptional Items
0.00
-5.40
5.40
100.00%
Gross Profit (PBDT)
49.35
129.70
-80.35
-61.95%
Depreciation
2.66
12.60
-9.94
-78.89%
Profit Before Tax
22.19
-34.10
56.29
165.07%
Tax
5.14
0.00
5.14
Provisions and contingencies
0
0
0.00
Profit After Tax
17.05
-34.10
51.15
150.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.05
-34.10
51.15
150.00%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
17.05
-34.10
51.15
150.00%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
420.34
337.40
82.94
24.58%
Earnings per share (EPS)
0.69
-0.36
1.05
291.67%
Diluted Earnings per share
0.69
-0.36
1.05
291.67%
Operating Profit Margin (Excl OI)
28.98%
-12.62%
0.00
41.60%
Gross Profit Margin
35.31%
-10.73%
0.00
46.04%
PAT Margin
24.22%
-17.02%
0.00
41.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.04 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.71% vs 3.26% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 9.66% vs 15.05% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.71 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 8.92% vs 0.64% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 23.91% vs 16.95% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.31 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 13.24% vs -4.67% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 22.87% vs 11.90% in Jun 2025

Quarterly - Interest
Interest 0.13 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 0.00% vs 0.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.98%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025